Global Cardiac Cannula Market Size By Type (Venous Cannula, Arterial Cannula), By Application (Hospitals, Clinics), By Region, And Segment Forecasts, 2023 to 2032

The Global Cardiac Cannula Market was valued at USD 135 million in 2023 and is projected to reach USD 238 million by 2031, growing at a CAGR of 7.4% during the forecast period of 2023–2031. The growth of this market is fueled by the increasing prevalence of cardiovascular diseases (CVDs), the rising number of cardiopulmonary surgeries, and the advancement of minimally invasive surgical procedures. Cardiac cannulas are essential components used during cardiopulmonary bypass procedures, cardiac surgeries, and extracorporeal membrane oxygenation (ECMO) therapy. With the global rise in cardiac procedures, demand for high-performance and biocompatible cannulas continues to surge.

Drivers:

Rising Incidence of Cardiovascular Diseases:

The global burden of CVDs, such as coronary artery disease and heart failure, is driving the demand for effective surgical interventions, including cardiopulmonary bypass. This trend significantly increases the usage of cardiac cannulas.

Technological Advancements in Cannula Design:

Innovations such as flexible-tip, heparin-coated, and wire-reinforced cannulas are enhancing safety and performance during surgical procedures. These developments are encouraging greater adoption across cardiac centers.

Growing Aging Population:

The aging population, which is more prone to heart-related conditions, is contributing to a higher number of surgeries requiring cannulas. As life expectancy increases globally, the market outlook remains positive.

Restraints:

High Cost of Surgical Procedures and Equipment:

Cardiac surgeries are often expensive, especially in developing nations, limiting accessibility. The high cost of specialized cannulas further compounds this issue and may hinder market growth.

Risk of Postoperative Complications:

Despite their critical role, improper cannula use can lead to bleeding, thrombosis, and vessel damage. This risk mandates highly skilled professionals and stringent safety protocols, which can limit widespread use.

Opportunity:

Emerging Markets and Expanding Healthcare Access:

Countries in Asia-Pacific, Latin America, and Africa are witnessing rapid improvements in healthcare infrastructure. With increased investments in cardiac care facilities, these regions present robust growth opportunities.

Increased Application in ECMO Procedures:

With the rise in ECMO usage for treating respiratory and cardiac failure, particularly after the COVID-19 pandemic, there’s growing demand for cannulas suitable for long-term support and minimal trauma.

Market by System Type Insights:

By system type, arterial cannulas held the largest market share in 2023, driven by their frequent use in cardiopulmonary bypass surgeries. Arterial cannulas are critical for delivering oxygenated blood to the patient’s body. The venous cannula segment is expected to grow at the fastest rate during the forecast period, owing to rising usage in ECMO and minimally invasive cardiac interventions.

Market by End-use Insights:

Based on end-use, hospitals emerged as the largest revenue contributor in 2023, accounting for over 60% of the market. This dominance is due to the high volume of cardiac procedures performed in hospital settings, combined with access to advanced surgical equipment. The cardiac centers and specialty clinics segment is anticipated to grow rapidly, supported by the growing trend of outpatient surgeries and specialized care facilities.

Market by Regional Insights:

Regionally, North America dominated the global cardiac cannula market in 2023 due to its well-established healthcare system, high prevalence of cardiovascular conditions, and early adoption of advanced medical devices. However, Asia-Pacific is projected to exhibit the highest CAGR through 2031. Rapid urbanization, rising healthcare expenditure, and an increasing geriatric population are driving market expansion across countries like China, India, and Japan.

Competitive Scenario:

Key players in the global cardiac cannula market include Medtronic plc, LivaNova PLC, Terumo Corporation, Edwards Lifesciences Corporation, Getinge AB, Maquet Holding B.V. & Co. KG, Smiths Medical, Sorin Group, Bio-Medicus Inc., and Nipro Medical Corporation. These companies are actively involved in strategic initiatives such as product innovation, acquisitions, and geographical expansion.

Recent Developments Include:

In 2023, Medtronic launched an advanced heparin-bonded arterial cannula designed for improved biocompatibility and reduced thrombus formation.

In 2024, LivaNova announced a partnership with a leading cardiac care hospital network in Asia to expand its distribution of minimally invasive cannula systems.

In 2025, Terumo received FDA approval for a next-generation venous cannula intended for extended ECMO support.

Scope of Work – Global Cardiac Cannula Market

Report Metric Details

Market Size (2023) USD 135 million

Projected Market Size (2031) USD 238 million

CAGR (2023–2031) 7.4%

Market Segments By System Type (Arterial, Venous, Cardioplegia, Vent), By End-use (Hospitals, Cardiac Centers, ASCs), By Region

Growth Drivers Increasing cardiovascular surgeries, technological innovations, aging population

Opportunities ECMO adoption, emerging market expansion

Key Market Developments:

2023: Medtronic unveiled a low-resistance cannula for pediatric cardiac surgery, enhancing performance and reducing complications.

2024: Edwards Lifesciences acquired a catheter-based technology company to integrate with its cannula and cardiac surgery portfolio.

2025: Getinge introduced a novel dual-lumen cannula compatible with ECMO systems, aiming to improve long-term patient outcomes.

FAQs:

1) What is the current market size of the Global Cardiac Cannula Market?

The market was valued at USD 135 million in 2023.

2) What is the major growth driver of the Global Cardiac Cannula Market?

The increasing prevalence of cardiovascular diseases and the rising number of cardiac surgeries globally are the major growth drivers.

3) Which is the largest region during the forecast period in the Global Cardiac Cannula Market?

North America is the largest region, while Asia-Pacific is expected to witness the highest growth rate.

4) Which segment accounted for the largest market share in the Global Cardiac Cannula Market?

The arterial cannula segment held the largest market share in 2023.

5) Who are the key market players in the Global Cardiac Cannula Market?

Key players include Medtronic plc, LivaNova PLC, Terumo Corporation, Edwards Lifesciences, and Getinge AB.